KIMBERLY MANHARD

CIK 1202094 · EVP, Drug Development · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$933.3K

Companies

4

Total Filings

86

Lifetime Open-Market Net

-$6.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INBX Director 10,000 $92.20 $922.0K $139.8K 7 2026-06-04
Inhibrx, Inc. (INBXV) Delisted Director $0 1 2024-05-30
HRTX EVP, Drug Development 28,330 $0.40 $11.3K -$2.65M 33 2023-04-17
Ardea Biosciences, Inc./DE (RDEA) Delisted SVP, Regulatory & Dev Ops 0 -$3.90M 43 2012-06-20

Recent Filings · Page 3 of 9

86 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-04-15 HRTX Mixed +817 -$7.2K EDGAR
2021-01-15 HRTX Mixed +817 -$7.9K EDGAR
2020-12-23 HRTX Mixed -$70.0K EDGAR
2020-10-15 HRTX Grant (A) $0 EDGAR
2020-08-21 INBX Grant (A) $0 EDGAR
2020-05-01 HRTX Mixed -$2.1K EDGAR
2019-12-23 HRTX Grant (A) $0 EDGAR
2019-12-03 HRTX Mixed -$312.0K EDGAR
2019-05-02 HRTX Mixed -$481 EDGAR
2018-12-18 HRTX Grant (A) $0 EDGAR
Showing 2130 of 86
Page 3 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.